The success of crizotinib in ALK-positive patients has elicited efforts to find new oncogenic
fusions in lung cancer. These efforts have led to the discovery of novel oncogenic fusion …

The aim of this study was to determine the distribution of known oncogenic driver mutations
in female never-smoker Asian patients with lung adenocarcinoma. We analyzed 214 …

MET, a cell surface receptor for hepatocyte growth factor, is involved in the development of
triple‐negative/basal‐like breast cancer (TNBC/BLBC). However, its utility as a therapeutic …

Introduction Response to mesenchymal-epithelial transition (MET) inhibitors in NSCLC with
mesenchymal-epithelial transition gene (MET) exon 14 skipping (METex14) has fueled …

Most anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancers (NSCLCs)
show good clinical response to ALK inhibitors. However, some ALK‐rearranged NSCLC …

Solitary fibrous tumors (SFTs) are NAB2-STAT6 fusion-associated neoplasms. There are
several subtypes of NAB2-STAT6 fusions, but their clinical significances are still unclear. …

Surgery and radiation are the current standard treatments for cervical cancer. However, there
is no effective therapy for metastatic or recurrent cases, necessitating the identification of …

Amplification and overexpression of MDM2 and CDK4 are well-known diagnostic criteria for
well-differentiated liposarcoma (WDLPS)/dedifferentiated liposarcoma (DDLPS). Although it …

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized
by poor patient prognosis and for which no targeted therapies are currently available. TNBC …

The paper presents the design of a wide-band active-RC filter with a fast tuning circuit for
wireless communication receiver applications. The filter topology is the 5/sup th/-order …